New Frontiers in Cardiovascular Research and Therapy
New Frontiers in Cardiovascular Research and Therapy
批准号:
10318721
负责人:
Elizabeth M McNally
金额:
$2.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-20 至 2022-06-30
关键词:
AddressAmerican Heart AssociationAwardBackCardiovascular DiseasesCardiovascular systemChicagoClinicalCollaborationsDisciplineDiseaseEpigenetic ProcessEquilibriumEventEyeFeedbackFundingGeneticGenomicsGeographic LocationsGoalsHeart DiseasesHeart failureHypertrophyInflammationInternationalInvestigationJournalsKnowledgeLeadershipLocationLogisticsMalignant NeoplasmsMedicineMolecularNational Heart, Lung, and Blood InstituteOralOutcomeParticipantPathogenesisPathway interactionsPersonsPhaseRequest for ProposalsResearchResearch PersonnelRunningScheduleScienceScientistSecureSideTherapeuticTherapeutic StudiesTravelWomanWorkcardiovascular healthcareercytotoxicitydesigndiversity and inclusionfrontiermeetingsmembernext generationnoveloxidationpostersprecision medicinepredictive markerprogramssuccesssymposiumvirtual
中文摘要
项目总结
这项提案要求NHLBI支持理事会关于基础设施的科学会议
美国心脏协会(AHA)心血管科学(BCVS)。这场会议已经变成了一场
为基础和转化性心血管科学会议提供机会
新兴的调查人员介绍他们的工作并收到建设性的反馈。2021年的会议
代表连续第十六届年会。国家对BCVS科学会议的资助
心、肺和血液研究所(NHLBI)在过去15年中有14年是安全的。BCVS的夏天
会议题为心血管和研究治疗的新前沿,定于7月26日-
2021年2月29日。在2020年,我们提供了一个具有并发会议的虚拟会议,参加会议的有
超过1000名参与者。2021年,会议将于周一开始,一直持续到周四。在2021年,
如果可能的话,我们将在芝加哥举行会议。如果我们不能亲自开会,
我们将转向2020年会议所使用的非常成功的虚拟格式。会议将突出强调
对心血管健康和疾病有影响的基础心血管研究。有17个预定的
会议包括老牌和新兴调查人员的混合。主旨演讲将由
道格拉斯·曼博士。对于那些处于职业生涯早期阶段的人来说,有一个特别的课程。我们将举办特别节目
交流课程,包括与期刊编辑和工作人员的互动。我们还将把女性包括在
科学网络活动。在每一步,我们都注重多样性和包容性,以促进最好的
心血管科学。本R13提案旨在为年轻调查人员提供支持,以使
以口头或海报形式作为主持人参加会议。主要的组织者是Dr.
皮拉尔·阿尔凯德和苏曼思·普拉布。计划委员会(12名成员)包括过去的计划共同-
主席和不同的领导层(包括美国和国际),来自
BCVS。AHA将继续为后勤提供出色的行政支持,并配备敬业的工作人员
会议的最新进展。我们完全期待这个团队将协调举办一次出色的2021年BCVS会议。
英文摘要
PROJECT SUMMARY
This proposal requests NHLBI support for the Scientific Sessions meeting presented by the Council on Basic
Cardiovascular Sciences (BCVS) of the American Heart Association (AHA). This meeting has become the “go
to” meeting for basic and translational cardiovascular sciences by providing opportunities for established and
emerging investigators to present their work and receive constructive feedback. The meeting in 2021
represents the sixteenth consecutive annual conference. Funding for BCVS Scientific Sessions from National
Heart, Lung and Blood Institute (NHLBI) has been secured for 14 of the last 15 years. The BCVS summer
conference is entitled New Frontiers in Cardiovascular and Research Therapy and is scheduled for July 26-
29, 2021. In 2020, we offered a virtual conference with concurrent sessions and the meeting was attended by
over 1000 participants. In 2021, the meeting will begin on a Monday and run through Thursday. In 2021,
should it be possible, we will hold the meeting in Chicago. Should we be unable to hold the meeting in person,
we will shift to the highly successful virtual format used for the 2020 meeting. The conference will highlight
basic cardiovascular research with implications for cardiovascular health and disease. There are 17 scheduled
sessions that include a mix of established and emerging investigators. The keynote address will be given by
Dr. Douglass Mann. There is a specific session for those in the early career phase. We will host special
sessions for networking including interactions with journal editors and staff. We will also include the Women in
Science networking event. At every step, we focus on diversity and inclusivity to promote the very best
cardiovascular science. This R13 proposal is designed to provide support to young investigators to enable
their participation in the meeting as presenters either in oral or poster format. The primary organizers are Drs.
Pilar Alcaide and Sumanth Prabhu. The Program Committee (12 members) includes the past program co-
chairs and a diverse leadership (both US and international) drawn from the many disciplines encompassed by
BCVS. The AHA will continue to provide excellent administrative support with dedicated staff for the logistics
of the conference. We fully anticipate that this team will coordinate an outstanding 2021 BCVS conference.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bridging Basic and Translational Science in Cardiovascular Disease
-
批准号:10540546
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2022
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:10406096
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2021
-
负责人:Elizabeth M McNally
-
依托单位:
Failed Regeneration in the Muscular Dystrophies: Inflammation, Fibrosis and Fat - Administrative Supplement
-
批准号:10212504
-
项目类别:
-
资助金额:$40.39万
-
财政年份:2020
-
负责人:Elizabeth M McNally
-
依托单位:
New Directions in Biology and Disease of Skeletal Muscle
-
批准号:10400988
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:Elizabeth M McNally
-
依托单位:
Northwestern University Molecular and Translational Cardiovascular Training Program
-
批准号:10197196
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2017
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:10161812
-
项目类别:
-
资助金额:$59.82万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:9923714
-
项目类别:
-
资助金额:$65.03万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:9061822
-
项目类别:
-
资助金额:$54.36万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:10615197
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Myoferlin in muscle membrane fusion and repair
-
批准号:8990655
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:10403645
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Cardiomyopathy Genomes Project
-
批准号:9929858
-
项目类别:
-
资助金额:$5.21万
-
财政年份:2015
-
负责人:Elizabeth M McNally
-
依托单位:
Sarcoglycan in Myopathy and Muscle Membrane Stability
-
批准号:8915736
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2014
-
负责人:Elizabeth M McNally
-
依托单位:
New Directions in Biology and Disease of Skeletal Muscle
-
批准号:8720398
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2014
-
负责人:Elizabeth M McNally
-
依托单位:
Sarcoglycan in Myopathy and Muscle Membrane Stability
-
批准号:8786782
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2014
-
负责人:Elizabeth M McNally
-
依托单位:
Sarcoglycan in Myopathy and Muscle Membrane Stability
-
批准号:8987217
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2014
-
负责人:Elizabeth M McNally
-
依托单位:
New Directions in Biology and Disease of Skeletal Muscle
-
批准号:8400254
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2012
-
负责人:Elizabeth M McNally
-
依托单位:
Regulating fibrosis and muscle growth in the muscular dystrophies
-
批准号:8294625
-
项目类别:
-
资助金额:$126.29万
-
财政年份:2011
-
负责人:Elizabeth M McNally
-
依托单位:
Regulating fibrosis and muscle growth in the muscular dystrophies
-
批准号:8151770
-
项目类别:
-
资助金额:$125.65万
-
财政年份:2011
-
负责人:Elizabeth M McNally
-
依托单位:
Regulating fibrosis and muscle growth in the muscular dystrophies
-
批准号:9022569
-
项目类别:
-
资助金额:$114.18万
-
财政年份:2011
-
负责人:Elizabeth M McNally
-
依托单位:
海外基金